Experimental analysis reduces organ dysfunction and mortality in acute pancreatitis using L-17 compound, suggesting therapeutic potential.
Objective: to examine the possibility of reducing the severity of organ dysfunction and inflammatory response with the L-17 compound in a model of acute post-manipulation pancreatitis (APMP). Materials and Methods. APMP was modeled on 40 rats. Laboratory rats were distributed among control (n=20, without treatment) and experimental (n=20, with the introduction of the L-17 compound) groups. The daily dose of the compound was 40 mg/kg of rat body weight. Results. APMP developed in all animals. In the control group, persistent organ dysfunction and inflammatory response corresponded to a severe course of acute pancreatitis with a mortality rate of 70%. In the experimental group, there was a decrease in the severity of organ dysfunction and inflammatory response, with a decrease in mortality down to 30%. Conclusion.Administration of the L-17 compound reduced the severity of organ dysfunction and inflammatory response in experimentally modeled APMP.
No takes yet. Share an insight, caveat, or question.
Rantsev et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: